Zobrazeno 1 - 10
of 23
pro vyhledávání: '"G R, Standen"'
Publikováno v:
Clinical & Laboratory Haematology. 14:331-334
Autor:
G R Standen
Publikováno v:
Journal of Clinical Pathology. 44:979-982
Introduction Wiskott-Aldrich syndrome is a rare X-linked disorder which, in its fully expressed form, is recognised by the clinical triad of combined immune deficiency, thrombocytopenia, and eczema.' An increased risk of malignancy has also been repo
Publikováno v:
Clinical and laboratory haematology. 22(5)
Peripheral T cell lymphocytosis is a rare finding in association with malignant thymomas. In the majority of previous cases, the tumours have behaved aggressively with symptoms arising from local invasion. We describe a patient with ocular myasthenia
Publikováno v:
British journal of haematology. 109(2)
Publikováno v:
Thrombosis and haemostasis. 80(1)
The majority of patients with type 2N von Willebrand disease (VWD type 2N) have mutations in the region of the von Willebrand factor (VWF) gene encoding the factor VIII binding domain of VWF. Two mutations predominate among VWD type 2N patients: G281
Publikováno v:
Blood. 90(7)
We have shown previously that the Rhesus (Rh) polypeptides are the commonest targets for pathogenic anti-red blood cell (RBC) autoantibodies in patients with autoimmune hemolytic anemia (AIHA). The aim of the current work was to determine whether act
Publikováno v:
Thrombosis and haemostasis. 77(1)
A new genetic test has been developed for detection of the mutation known as factor V Leiden. The test employs heteroduplex technology and comprises a single PCR reaction followed immediately by PCR product analysis. It therefore represents the minim
Publikováno v:
Thrombosis and haemostasis. 75(2)
We have recently described a novel mutation screening technique for the diagnosis of type 2B von Willebrand's disease (vWD). Analysis involves the use of a synthetic universal heteroduplex generator (UHG). To test the validity of the technique, we ha
Autor:
B M, Kumpel, M J, Goodrick, D H, Pamphilon, I D, Fraser, G D, Poole, C, Morse, G R, Standen, G E, Chapman, D P, Thomas, D J, Anstee
Publikováno v:
Blood. 86(5)
The use of prophylactic anti-D to prevent Rh D immunization in Rh D- women and subsequent hemolytic disease in Rh D+ infants is widespread, but has led to shortages of the anti-D Ig. With the aim of substituting monoclonal anti-D for Rh D prophylaxis
Autor:
S, Aslam, G R, Standen
Publikováno v:
Thrombosis and haemostasis. 73(5)